Ultragenyx Pharmaceutical Inc. (0LIF.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
As of 03:16PM GMT. Market open.
| Previous close | 35.49 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | N/A |
| Market cap | 21.503M |
| Beta (5Y monthly) | 1.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.87 |
| Earnings date | 08 Feb 2023 - 13 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Ultragenyx Pharmaceutical (NASDAQ:RARE) shareholders have endured a 55% loss from investing in the stock a year ago
The nature of investing is that you win some, and you lose some. Unfortunately, shareholders of Ultragenyx...
- Zacks
Ultragenyx's (RARE) Q3 Earnings Miss Estimates, Revenues Up Y/Y
Ultragenyx (RARE) reports a wider-than-expected loss in the third quarter. Revenues, though up year over year, miss estimates.
- Zacks
Ultragenyx (RARE) Reports Q3 Loss, Misses Revenue Estimates
Ultragenyx (RARE) delivered earnings and revenue surprises of -6.11% and 8.16%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
